Drug‐Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles
Paola Nicoletti(University of Florence), Ann K. Daly(Newcastle University), John Dillon(Mayo Clinic), Munir Pirmohamed(University of Liverpool), Mariam Molokhia(Auckland University of Technology), Mohammad A. Alshabeeb(King Abdullah International Medical Research Center), Anke H. Maitland‐van der Zee(Utrecht University), Raúl J. Andrade(Hospital Clínico Universitario Virgen de la Victoria), Thomas C. Chamberlain(University of British Columbia), Pär Hallberg(Uppsala University), Matthew R. Nelson(Deerfield (United States)), Yufeng Shen(Columbia University Irving Medical Center), Jane I. Grove(Nottingham University Hospitals NHS Trust), M. Isabel Lucena(Hospital Clínico Universitario Virgen de la Victoria), Einar S. Björnsson(University of Iceland), Guruprasad P. Aithal(NIHR Nottingham Digestive Diseases Biomedical Research Unit), Jennifer Martin(Ministry of Children, Community and Social Services), Sally A. Coulthard(Newcastle University), Mia Wadelius(Uppsala University)
Cited by 93
Related Papers
Drug repurposing: progress, challenges and recommendations
|Nature Reviews Drug Discovery|2018|4.6k
The support of human genetic evidence for approved drug indications
|Nature Genetics|2015|1.8k
Reducing Inappropriate Polypharmacy
|JAMA Internal Medicine|2015|1.5k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k